Literature DB >> 22430272

Optimal colorectal cancer staging criteria in TNM classification.

Hideki Ueno1, Hidetaka Mochizuki, Yoshito Akagi, Takaya Kusumi, Kazutaka Yamada, Masahiro Ikegami, Hiroshi Kawachi, Shingo Kameoka, Yasuo Ohkura, Tadahiko Masaki, Ryoji Kushima, Keiichi Takahashi, Yoichi Ajioka, Kazuo Hase, Atsushi Ochiai, Ryo Wada, Keiichi Iwaya, Hideyuki Shimazaki, Takahiro Nakamura, Kenichi Sugihara.   

Abstract

PURPOSE: Histologic components of the TNM classification system have been repeatedly revised since the fifth edition (TNM5). TNM classification revisions provide different criteria for categorizing tumor nodules without residual lymph node structure (ND). However, there are few systematic evaluations regarding the effectiveness of these revisions. PATIENTS AND METHODS: A multicenter pathologic review for ND in colorectal cancer (CRC) was performed. Tumor staging defined by TNM5, sixth edition (TNM6), and seventh edition (TNM7) were compared on the basis of Akaike information criterion (AIC) and Harrell's concordance index (c-index). Moreover, TNM7's prognostic value was compared between the original ND and modified criteria, which considered all regional NDs as lymph node metastasis (LNM) irrespective of the original structure.
RESULTS: In 1,716 treated patients with CRC (1994 to 1998), tumor stages (I/II/III) exhibited better prognoses in TNM7 (AIC, 3055.1; c-index, 0.7215) than in TNM6 (AIC, 3063.7; c-index, 0.7149), but not better than in TNM5 (AIC, 3051.6; c-index, 0.7240). Comparing the original TNM7 and modified criteria, 4.2% of patients were classified in different N stages (N0/N1/N2a/N2b); both AIC and the c-index were superior in the modified criteria (AIC, 3029.40; c-index, 0.7271) compared with the original criteria (AIC, 3040.58; c-index, 0.7230). Modified criteria were also associated with improved prognostic power of tumor stages (I/IIA/IIB/IIC/IIIA/IIIB/IIIC). These results were similar in another cohort of 2,242 treated patients with CRC (1999 to 2003).
CONCLUSION: The prognostic value of TNM7 is better than that of TNM6; however, improvement over TNM5 is insignificant. By considering all regional NDs as LNM irrespective of their morphology, TNM classification can be simplified and its prognostic value improved.

Entities:  

Mesh:

Year:  2012        PMID: 22430272     DOI: 10.1200/JCO.2011.39.4692

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  42 in total

1.  Comparison of model fit and discriminatory ability of the 8th edition of the tumor-node-metastasis classification and the 9th edition of the Japanese classification to identify stage III colorectal cancer.

Authors:  Kei Kitamura; Dai Shida; Shigeki Sekine; Yuka Ahiko; Yuya Nakamura; Konosuke Moritani; Shunsuke Tsukamoto; Yukihide Kanemitsu
Journal:  Int J Clin Oncol       Date:  2021-06-03       Impact factor: 3.402

2.  Clinical characteristics and prognosis of young patients with colorectal cancer in Eastern China.

Authors:  Jian-Fei Fu; Yan-Qin Huang; Jiao Yang; Cheng-Hao Yi; Hai-Long Chen; Shu Zheng
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 3.  Management of nodal disease from colon cancer in the laparoscopic era.

Authors:  Corrado Pedrazzani; Lelde Lauka; Simone Sforza; Andrea Ruzzenente; Filippo Nifosì; GianGaetano Delaini; Alfredo Guglielmi
Journal:  Int J Colorectal Dis       Date:  2014-11-22       Impact factor: 2.571

4.  Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy?

Authors:  H Ishida; K Kumamoto; K Ishibashi; S Hatano; T Matsuzawa; N Okada; Y Kumagai; H Baba; N Haga
Journal:  Tech Coloproctol       Date:  2013-02-07       Impact factor: 3.781

5.  Impact of clinical tumor-node-metastasis staging on survival in gastric carcinoma patients receiving surgery.

Authors:  Etsuro Bando; Rie Makuuchi; Masanori Tokunaga; Yutaka Tanizawa; Taiichi Kawamura; Masanori Terashima
Journal:  Gastric Cancer       Date:  2016-09-01       Impact factor: 7.370

6.  LSF expression and its prognostic implication in colorectal cancer.

Authors:  Hui Jiang; Jun Du; Jianqiang Jin; Xiaowei Qi; Yong Pu; Bojian Fei
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 7.  Evolving notions on immune response in colorectal cancer and their implications for biomarker development.

Authors:  Fabio Grizzi; Gianluca Basso; Elena Monica Borroni; Tommaso Cavalleri; Paolo Bianchi; Sanja Stifter; Maurizio Chiriva-Internati; Alberto Malesci; Luigi Laghi
Journal:  Inflamm Res       Date:  2018-01-10       Impact factor: 4.575

8.  Clinicopathological characteristics of colorectal cancer presenting under the age of 50.

Authors:  Huw G Jones; Rami Radwan; Mark Davies; Martyn Evans; Umesh Khot; T V Chandrasekaran; Namor Williams; Alex Murray; Wendy Jones; Dean Harris; John Beynon
Journal:  Int J Colorectal Dis       Date:  2015-02-24       Impact factor: 2.571

9.  Marked impact of tumor location on the appropriate cutoff values and the prognostic significance of the lymph node ratio in stage III colon cancer: a multi-institutional retrospective analysis.

Authors:  Eiji Shinto; Hideyuki Ike; Jin-Ichi Hida; Hirotoshi Kobayashi; Yojiro Hashiguchi; Yoshiki Kajiwara; Kazuo Hase; Hideki Ueno; Kenichi Sugihara
Journal:  J Gastroenterol       Date:  2019-01-01       Impact factor: 7.527

10.  Transmembrane mucin MUC1 overexpression and its association with CD10⁺ myeloid cells, transforming growth factor-β1 expression, and tumor budding grade in colorectal cancer.

Authors:  Do Trong Khanh; Eiji Mekata; Ken-ichi Mukaisho; Hiroyuki Sugihara; Tomoharu Shimizu; Hisanori Shiomi; Satoshi Murata; Shigeyuki Naka; Hiroshi Yamamoto; Yoshihiro Endo; Tohru Tani
Journal:  Cancer Sci       Date:  2013-05-21       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.